Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
08/2013
08/27/2013US8519137 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels
08/27/2013US8518999 Modulators of TNF-αsignaling
08/27/2013US8518983 P38 inhibitors and methods of use thereof
08/27/2013US8518968 Hydrazone and diacyl hydrazine compounds and methods of use
08/27/2013US8518560 Aromatic amine derivative and organic electroluminescent device using the same
08/27/2013CA2754998C Substituted nicotinamides as kcnq2/3 modulators
08/27/2013CA2658215C An enantioselective synthesis of pyrrolidines-substituted flavones
08/27/2013CA2657776C Triazolyl phenyl benzenesulfonamides
08/27/2013CA2531868C Process for the preparation of thalidomide
08/22/2013WO2013123444A1 Sulfonyl compounds that interact with glucokinase regulatory protein
08/22/2013WO2013123401A1 Diaminopyrimidines useful as inhibitors of the human respiratory syncytial virus (rsv)
08/22/2013WO2013123165A1 Crystalline form of (2s,4r)-5-biphenyl-4-yl-2-hydroxymethyl-2-methyl-4-[(1h-[1,2,3]triazole-4-carbonyl)-amino]-pentanoic acid [1,3]dioxol-4-ylmethyl ester
08/22/2013WO2013120921A1 Novel pyrrolidine derivatives
08/22/2013WO2013120876A1 CF3O-containing enaminoketones and their utilization for the preparation of CF3O-containing pyrazoles
08/22/2013WO2013120835A1 Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy
08/22/2013WO2013062966A3 Methanol derivatives as trpv3 modulators
08/22/2013US20130217887 Compounds With Matrix-Metalloproteinase Inhibitory Activity and Imaging Agents Thereof
08/22/2013US20130217730 Polysubstituted benzofurans and medicinal applications thereof
08/22/2013US20130217728 New ccr2 antagonists
08/22/2013US20130217726 Insulin-regulated aminopeptidase (irap) inhibitors and uses thereof
08/22/2013US20130217715 Derivatives of pyrazolophenyl-benzenesulfonamide compounds and use thereof as antitumor agents
08/22/2013US20130217709 Cyclic Amine Azaheterocyclic Carboxamides
08/22/2013US20130217704 Compositions and methods for inhibiting cytochrome p450 2d6
08/22/2013US20130217701 Compositions of azimilide dihydrochloride
08/22/2013US20130217700 Pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
08/22/2013US20130217685 Compounds for modulating rna binding proteins and uses therefor
08/22/2013US20130217680 Inhibitors of the Renal Outer Medullary Potassium Channel
08/22/2013US20130217670 Quinoxaline derivatives
08/22/2013US20130217665 Novel pyrrolidine derivatives
08/22/2013US20130217650 Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors
08/21/2013EP2628729A1 Aromatic heterocyclic derivative, and organic electroluminescent element comprising same
08/21/2013EP2628726A1 Hydroxamate-based inhibitors of deacetylases b
08/21/2013EP2628722A1 CF3O-containing enaminoketones and their utilization for the preparation of CF3O-containing pyrazoles
08/21/2013EP2627649A1 Cxcr4 receptor antagonists
08/21/2013EP2627634A1 A new dimedon derivative and a method for the purification of pna and peptide oligomers
08/21/2013EP2627631A1 Pyrrolidinones as metap2 inhibitors
08/21/2013EP2627324A2 Substituted benzamides and their uses
08/21/2013CN103262283A Organic electroluminescent element
08/21/2013CN103261190A Novel benzofurane compounds
08/21/2013CN103261189A Amino-pyrrolidine-zetidine diamides as monoacylglycerol lipase inhibitors
08/21/2013CN103261165A 胰高血糖素受体调节剂 Glucagon receptor modulators
08/21/2013CN103261157A Strigolactam derivatives and their use as plant growth regulators
08/21/2013CN103261156A New compounds for the treatment of neurodegenerative diseases
08/21/2013CN103254184A 5-substituted-3-[5-hydroxy-4-pyrone-2-yl-methylmercapto]-4-amino-1,2,4-triazole compound and application thereof
08/21/2013CN103254183A Method for preparing Afatinib
08/21/2013CN103254182A Method for preparing Afatinib
08/21/2013CN103254181A Extraction method of acridine coumarin alkali F
08/21/2013CN103254177A Modulators of atp-binding cassette transporters
08/21/2013CN103254113A Aromatic amine derivative and organic electroluminescence device using same
08/21/2013CN102321076B Preparation method of lapatinib intermediate and analogues thereof
08/21/2013CN101851244B Substituted phenyl keto enols as pesticides and herbicides
08/21/2013CN101790517B Inhibitor of binding of s1p1
08/21/2013CN101712867B Organic electronic transmission and/or hole barrier materials, synthetic method and applications thereof
08/21/2013CN101591322B Cyclin dependent kinases inhibitor scutellaria flavonoid organic amine derivatives, preparation method and application thereof
08/21/2013CN101421258B Sulfonyl-substituted bicyclic compounds as modulators of ppar
08/20/2013US8513424 Pyridone GPR119 G protein-coupled receptor agonists
08/20/2013US8513293 Methods of treating a hyperproliferative disorder or inhibiting cell growth in a mammal
08/20/2013US8513268 1H-quinazoline-2,4-diones processes for their production, pharmaceutical compositions, and treatment for epilepsy
08/20/2013US8513262 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
08/20/2013US8513253 α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors
08/20/2013US8513237 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
08/20/2013US8513235 Homocysteine synthase inhibitor
08/15/2013WO2013119895A1 Heteroaryl compounds and methods of use thereof
08/15/2013WO2013119499A1 Novel compounds for the treatment of hepatitis c
08/15/2013WO2013118097A1 Antiviral compounds with a dibenzooxaheterocycle moiety
08/15/2013WO2013117749A1 Pyrrolic derivatives, processes for preparing the same and their uses as a drug
08/15/2013WO2013117645A1 Imidazo [4, 5 -c] pyridine derivatives useful for the treatment of degenerative and inflammatory diseases
08/15/2013WO2013062964A3 Methanol derivatives as trpv3 modulators
08/15/2013US20130211098 Process for preparing 4-amino-5-biphenyl-4-yl-2-hydroxymethyl-2-methyl-pentanoic acid compounds
08/15/2013US20130211086 Purification of posaconazole and of posaconazole intermediates
08/15/2013US20130211076 Method for preparing substituted N-(3-amino-quinoxalin-2-yl)-sulfonamides and their intermediates N-(3-chloro-quinoxalin-2-yl)-sulfonamides
08/15/2013US20130211075 Amide derivative and use thereof
08/15/2013US20130210886 Novel Derivatives Useful as Antiviral Agents
08/15/2013US20130210880 Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy
08/15/2013US20130210858 Sulfamoyl benzoic acid heterobicyclic derivatives as trpm8 antagonists
08/15/2013US20130210818 Novel Heterocyclic Compounds and Uses Thereof
08/15/2013US20130210814 Cycloalkyl Substituted Pyrimidinediamine Compounds And Their Uses
08/15/2013US20130210811 Picolinamide and pyrimidine-4-carboxamide compounds, process for preparing and phamaceutical composition comprising the same
08/15/2013US20130210805 Quinazolinone-type compounds as crth2 antagonists
08/15/2013US20130210800 Pyridine-2-derivatives as smoothened receptor modulators
08/15/2013US20130210795 Substituted dicyanopyridines and use thereof
08/15/2013US20130210773 Indole compounds as positive allosteric modulators of the muscarinic receptor
08/15/2013US20130210772 Androgen induced oxidative stress inhibitors
08/15/2013US20130210625 Spiroheterocyclic pyrrolidine derivatives based pesticides
08/15/2013US20130209505 Crystalline form of (2s,4r)-5-biphenyl-4-yl-2-hydroxymethyl-2-methyl-4-[(1h-[1,2,3]triazole-4-carbonyl)-amino]-pentanoic acid 5-methyl-2-oxo-[1,3]dioxol-4-ylmethyl ester
08/14/2013EP2626947A1 Photoelectric conversion element, pigment for photoelectric conversion element and compound
08/14/2013EP2626358A1 Immunoassay for pyrrolidinophenones
08/14/2013EP2626357A1 Pyrrolic derivatives, processes for preparing the same and their uses as antibiotics
08/14/2013EP2626354A1 Viral polymerase inhibitors
08/14/2013EP2626352A1 Heterocyclic low-molecular sapp mimetics, a pharmaceutical composition and methods for producing and using same
08/14/2013EP2626348A1 Heterocyclic amides as rock inhibitors
08/14/2013EP2625171A1 Phenanthro[9,10-b]furans for electronic applications
08/14/2013EP2625167A1 Salts and polymorphs of sulfamide ns3 inhibitors
08/14/2013EP2625166A1 Oxime ester derivatives of benzocarbazole compounds and their use as photoinitiators in photopolymerizable compositions
08/14/2013EP2624697A1 Dihydrobenzoquinazolinone m1 receptor positive allosteric modulators
08/14/2013EP2624696A1 Benzimidazole derivatives as pi3 kinase inhibitors
08/14/2013CN103249731A Hepatitis c virus inhibitors
08/14/2013CN103249729A Anthranilic acid diamide derivatives with cyclical side chains
08/14/2013CN103249728A Novel triazole compounds III
08/14/2013CN103249727A New biaryl amide derivatives
1 ... 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 ... 694